Amgen Inc. (AMGN)

Amgen (AMGN) stock is at an interesting point right now. If you bet on it, you are betting on a company that's growing reasonably, is sustaining good cash flow and margin, has low-debt capital structure, and is relatively cheaply valued.

To see the full list of analyst forecasts on Amgen stock, see the AMGN Stock Forecast page. ... According to Spark, TipRanks’ AI Analyst, AMGN is a Neutral. AMGN scores well on core operating fundamentals (strong margins and durable free cash flow) and is supported by a positive earnings-call ...

Amgen Inc. (NASDAQ:AMGN) is one of Louis Navellier’s top long-term stock picks. On May 14, Piper Sandler reiterated an Overweight rating on Amgen Inc. (NASDAQ:AMGN) but lowered the price target to $427 from $432. The new price target still represents significant upside potential as the research ...

PNC Financial Services Group Inc. decreased its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 5.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,048,963 shares of the medical research company's stock after selling 66,

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.